Skip to main content

Articles

Page 127 of 151

  1. Abnormalities in lymphocyte signaling cascades are thought to play an important role in the development of autoimmune disease. However, the large amount of cellular material needed for standard biochemical ass...

    Authors: Amrie C Grammer, Randy Fischer, Olivia Lee, Xuan Zhang and Peter E Lipsky
    Citation: Arthritis Res Ther 2004 6:28
  2. Autoimmune diseases are often characterized as clinical syndromes caused by the inappropriate activation of T or B cells resulting in systemic or organ-specific damage. However, studies support a role for the ...

    Authors: Anthony R French and Wayne M Yokoyama
    Citation: Arthritis Res Ther 2003 6:8
  3. The chimeric anti-CD20 monoclonal antibody rituximab has been used extensively in the treatment of B cell malignancies, and more recently it has emerged as a potential treatment for rheumatoid arthritis (RA), ...

    Authors: John D Hainsworth
    Citation: Arthritis Res Ther 2003 5(Suppl 4):S12

    This article is part of a Supplement: Volume 5 Supplement 4

  4. B lymphocytes play several critical roles in the pathogenesis of rheumatoid arthritis. They are the source of the rheumatoid factors and anticitrullinated protein antibodies, which contribute to immune complex...

    Authors: Gregg J Silverman and Dennis A Carson
    Citation: Arthritis Res Ther 2003 5(Suppl 4):S1

    This article is part of a Supplement: Volume 5 Supplement 4

  5. Antibodies directed to citrullinated proteins (anti-cyclic citrullinated peptide) are highly specific for rheumatoid arthritis (RA). Recent data suggest that the antibodies may be involved in the disease proce...

    Authors: Erik R Vossenaar, Albert JW Zendman and Walther J van Venrooij
    Citation: Arthritis Res Ther 2003 6:1
  6. It is widely accepted that cell-mediated immune functions decline with age, rendering an individual more susceptible to infection and possibly cancer, as well as to age-associated autoimmune diseases. The exac...

    Authors: Tamàs Fülöp Jr, Anis Larbi, Gilles Dupuis and Graham Pawelec
    Citation: Arthritis Res Ther 2003 5:290
  7. Recent advances in the study of global patterns of gene expression with the use of microarray technology, coupled with data analysis using sophisticated statistical algorithms, have provided new insights into ...

    Authors: Mary K Crow and Jay Wohlgemuth
    Citation: Arthritis Res Ther 2003 5:279
  8. Synovial tissue is readily accessible by closed needle or arthroscopic biopsy. These techniques provide adequate tissue for most diagnostic requirements. Examination of synovial tissue can assist in the diagno...

    Authors: Barry Bresnihan
    Citation: Arthritis Res Ther 2003 5:271
  9. The CD20 cell marker appears early in the process of B cell development. In this review we focus on the results of attempts to utilize B cell depletion based on the use of a chimeric monoclonal antibody (MAb) ...

    Authors: Claire Gorman, Maria Leandro and David Isenberg
    Citation: Arthritis Res Ther 2003 5(Suppl 4):S17

    This article is part of a Supplement: Volume 5 Supplement 4

  10. The role of B cells in rheumatoid arthritis (RA) has been debated for decades. However, recent clinical trial data indicating that depletion of B cells in RA patients is of therapeutic benefit has validated th...

    Authors: Thomas J Oligino and Stacie A Dalrymple
    Citation: Arthritis Res Ther 2003 5(Suppl 4):S7

    This article is part of a Supplement: Volume 5 Supplement 4

  11. Inflammation and inflammatory responses are modulated by a bidirectional communication between the neuroendocrine and immune system. Many lines of research have established the numerous routes by which the imm...

    Authors: Farideh Eskandari, Jeanette I Webster and Esther M Sternberg
    Citation: Arthritis Res Ther 2003 5:251

Annual Journal Metrics

  • 2022 Citation Impact
    4.9 - 2-year Impact Factor
    5.7 - 5-year Impact Factor
    1.501 - SNIP (Source Normalized Impact per Paper)
    1.592 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    111 days submission to accept (Median)

    2023 Usage 
    3,331,819 downloads
    1,885 Altmetric mentions